Addressing US Demand for Psychedelic Medicines in the Face of Scientific Uncertainty.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics January 1, 2026 Holly Fernandez Lynch, Xinping Hu, Alison Bateman-House 2 citations
Psychedelic medicines show potential for treating serious mental health conditions, creating demand before FDA approval. Policymakers should balance evidence, patient safety, and speed by increasing research support, avoiding barriers to research, improving FDA's pre-approval access, and preventing politically driven approvals.